ArticleCureus2025
Trends in Prescription Medication Use for Depression Symptoms: An Analysis of National Health Interview Survey (NHIS) Data From 2019 to 2023.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Reflex vasodilation and sweating in response to passive whole body heating are blunted in women with major depressive disorder.Journal of applied physiology (Bethesda, Md. : 1985) · 2026Article
- Antidepressant Use and Risk of Reoperation After Distal Radius Open Reduction and Internal Fixation: A Propensity Score-Matched Cohort Study.Journal of hand surgery global online · 2026Article
- Antidepressant use among American adults in a 50-state survey.BMJ mental health · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression is a major public health concern, and antidepressant medication is commonly prescribed for its management. Understanding trends in antidepressant use across socio-demographic groups is crucial for targeted interventions.
objectiveTo analyze trends in antidepressant medication use between 2019 and 2023 using data from the National Health Interview Survey (NHIS), focusing on demographic factors such as gender, age, race, and social vulnerability.
methodData from the NHIS (2019-2023) were analyzed to assess trends in antidepressant use by sociodemographic variables. Descriptive statistics and trends were evaluated using prevalence estimates with confidence intervals.
resultOverall, antidepressant use increased from 9.8% (95% CI: 9.4-10.3) in 2019 to 11.4% (95% CI: 11.0-11.9) in 2023 (
conclusionThe study reveals a steady increase in antidepressant use from 2019 to 2023, particularly among females, older adults, and individuals with higher social vulnerability or disabilities. Racial disparities in antidepressant use persist, with White individuals showing the highest prevalence. These findings highlight the ongoing need for targeted mental health interventions, especially for vulnerable groups, and underscore the importance of addressing disparities in access to mental health care. Future research should focus on the factors driving these trends and their implications for public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.